Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-044079

Director sold 4,731 shares at an average $24.58 ($116,281)

  • Director acquired 4,096 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Welgus Howard G. · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Exercise or conversion : show line 1 in the form 10b5-1 +822 $6.52 $5,361 39,200 D
2026-06-15 Exercise or conversion : show line 2 in the form 10b5-1 +1,019 $7.51 $7,653 40,219 D
2026-06-15 Exercise or conversion : show line 3 in the form 10b5-1 +2,255 $8.63 $19,461 42,474 D
2026-06-15 Sale : show line 4 in the form 10b5-1 −4,096 $24.41 $99,980 38,378 D
2026-06-17 Sale : show line 5 in the form 10b5-1 −635 $25.67 $16,300 37,743 D
Open-market sales · 4,731 sh · avg $24.58 · $116,281

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-06-15 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −822 9,040 D
2026-06-15 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −1,019 11,201 D
2026-06-15 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −2,255 24,797 D
Loading xslF345X06/wk-form4_1781743212.xml…